Streptococcus suis
(
S. suis
), more specifically serotype 2, is a bacterial pathogen that threatens the lives of pigs and humans. Like many other pathogens,
S. suis
exhibits quorum sensing (QS) system-controlled virulence factors, such as biofilm formation that complicates treatment. Therefore, impairing the QS involving LuxS/AI-2 cycle in
S. suis
, may be a promising alternative strategy for overcoming
S. suis
infections. In this study, we investigated paeoniflorin (PF), a monoterpenoid glycoside compound extracted from peony, as an inhibitor of
S. suis
LuxS/AI-2 system. At a sub-minimal inhibitory concentration (MIC) (1/16 MIC; 25 μg/ml), PF significantly reduced biofilm formation by
S. suis
through inhibition of extracellular polysaccharide (EPS) production, without affecting bacterial growth. Moreover, evidence was brought that PF reduces AI-2 activity in
S. suis
biofilm. Molecular docking indicated that LuxS may be the target of PF. Monitoring LuxS enzymatic activity confirmed that PF had a partial inhibitory effect. Finally, we showed that the use of PF in a mouse model can relieve
S. suis
infections. This study highlighted the anti-biofilm potential of PF against
S. suis
, and brought evidence that it may as an inhibitor of the LuxS/AI-2 system to prevent
S. suis
biofilm-related infections. PF can thus be used as a new type of natural biofilm inhibitor for clinical application.